Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SIMPLE: Stent Implantation vs Medical Therapy for Idiopathic Intracranial Hypertension
NCT05707442Phase 3Recruiting
- Sponsor
- Beijing Tiantan Hospital
- Start
- Feb 2023
- Primary completion
- Jan 2027
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial in idiopathic intracranial hypertension (IIH) and Venous sinus stenosis (VSS) (2 arms), sponsored by Beijing Tiantan Hospital. Primary endpoint: Perimetric Mean Deviation at 6 months. Started Feb 2023; status: recruiting.
02
Conditions
idiopathic intracranial hypertension (IIH)Venous sinus stenosis (VSS)
Beyond the preview
Go deeper on NCT05707442.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05707442.